2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Abstract

Research Snapshot Theater: Pharmacology, Adult IV

Sunday, March 22, 2026
2:30 PM - 3:30 PM Central Time
Location: Connections Central - RST 08

Presentations:

  • 2:30 PM - 3:30 PM Central Time
    Safety of Coadministration of Propofol and Clevidipine: A Multi-Site Retrospective Analysis

    Micaela Warfield, PharmD – Mayo Clinic

    Caitlin S. Brown, BCCCP, PharmD, FCCM (she/her/hers) – Mayo Clinic

    Kristin C. Cole, MS – Mayo Clinic

    Kiyan Heybati, MD, MS – Mayo Clinic

    Erin Wieruszewski, PharmD, BCCCP – Mayo Clinic

    Hemang Yadav, MBBS – Mayo Clinic

    Alejandro Rabinstein, MD – Mayo Clinic

    Nicholas Vollmer, BCCCP, PharmD – Mayo Clinic

  • 2:30 PM - 3:30 PM Central Time
    Management of Combined Opioid and Medetomidine Withdrawal at an Academic Medical Center

    Tyler Boyce, MD (he/him/his)

    Emily Casey, PharmD – Hospital of the University of Pennsylvania

    Shannon Lawson, PharmD, BCCCP – Hospital of The University of Pennsylvania

    Michael DiCesare, PharmD, BCCCP – Hospital of the University of Pennsylvania

    Samantha Huo, MD, MPH – Hospital of the University of Pennsylvania

    Oscar Mitchell, MD, MSCE – University of Pennsylvania Perelman School of Medicine

    Katharine Secunda, MD (she/her/hers) – University of Pennsylvania

    Jeanmarie Perrone, MD – Hospital of the University of Pennsylvania

    William D. Schweickert, MD – University of Pennsylvania

    Bridget Durkin, MD, MBE – Hospital of the University of Pennsylvania

    Brian Anderson, MD MSCE – Hospital of the University of Pennsylvania

  • 2:30 PM - 3:30 PM Central Time
    Effect of Implementation of an Albumin Criteria for Utilization at an Academic Medical Center

    Brynna Elisabeth Crovetto, PharmD, BCCCP, BCPS (she/her/hers) – NYC Health + Hospitals Bellevue

    Andrew Straznitskas, PharmD, BCCCP – NYC Health + Hospitals Bellevue

    Hannah Otiker, PharmD

    Vikramjit Mukherjee, MD – NYC Health + Hospitals/Bellevue Hospital Center

  • 2:30 PM - 3:30 PM Central Time
    Impact of Perioperative Intravenous Acetaminophen on Opioid Consumption Post-Cardiothoracic Surgery

    Ashley Taylor, PharmD, BCCCP – Augusta University Medical Center

    Rachel Robinson, PharmD, BCCCP – Self Regional Medical Center

    Nathaniel Wayne, PharmD, BCCP, BCPS, AACC – Wellstar MCG Health

    Aaron Chase, PharmD, BCCCP – MUSC

    Vijay Patel, MD – Wellstar MCG Health

    Akbar Herekar, MD – Wellstar MCG Health

    Ankit Jain, MBBS, FASE, FASA, MBA – Wellstar MCG Health

  • 2:30 PM - 3:30 PM Central Time
    Comparison of Initial Sedation and Analgesia in Patients on Buprenorphine vs Opioid-Naive Patients

    Anna Piotrowicz, PharmD (she/her/hers) – null

    Aeryana Bektas, PharmD, BCCCP – Mayo Clinic

    Emily Casey, PharmD – Hospital of the University of Pennsylvania

    Tanya Uritsky, PharmD, BCPP – Hospital of the University of Pennsylvania

    Nikitha Yagnala, PharmD – Hospital of the University of Pennsylvania

  • 2:30 PM - 3:30 PM Central Time
    Hemodynamic Effects of Ketamine Versus Etomidate for RSI in Critically Ill Patients

    Felipe Hinojosa, PharmD (he/him/his) – Ascension Seton

    Kaitlyn Dalton, PharmD, BCCCP – Ascension Seton

    Hannah Kim, PharmD – Ascension Seton

  • 2:30 PM - 3:30 PM Central Time
    Evaluation of Inhaled Epoprostenol Use in the Intensive Care Unit

    Rachel Bishop, PharmD (she/her/hers)

    Stephanie Toole, PharmD – Tampa General Hospital

    Christine Groth, BCCCP, PharmD, FCCM – Strong Memorial Hospital of the University of Rochester

    Jenna Corvelli, PharmD, BCCCP – University of Rochester Medical Center

    Renae Gozelski, PharmD, BCCCP – University of Rochester

  • 2:30 PM - 3:30 PM Central Time
    Fatal Toxic Exposure: Fentanyl, “Dust-Off,” or Both?

    Armando R. Yparraguirre, Medical Doctor (he/him/his) – University of Nevada, Reno School of Medicine

    Fernando Fuentes, Medical Doctor – National Jewish Health